About us Contacts Drug interactions: 390 212
Drug search by name

Nefazodone Hydrochloride and Vanspar

Determining the interaction of Nefazodone Hydrochloride and Vanspar and the possibility of their joint administration.

Check result:
Nefazodone Hydrochloride <> Vanspar
Relevance: 03.12.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using busPIRone together with nefazodone may increase the effects of busPIRone. Contact your doctor if you experience nausea, vomiting, dizziness, irritability, altered consciousness, confusion, drowsiness, blurred vision, and stomach pain. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

ADJUST DOSE: Coadministration with nefazodone may significantly increase the plasma concentrations and pharmacologic effects of buspirone. The mechanism is nefazodone inhibition of CYP450 3A4, the isoenzyme responsible for the metabolic clearance of buspirone. In healthy volunteers, administration of buspirone (2.5 or 5 mg twice a day) in combination with nefazodone (250 mg twice a day) increased steady-state buspirone peak plasma concentration (Cmax) by up to 20-fold and systemic exposure (AUC) by up to 50-fold. Plasma concentrations of the pharmacologically active metabolite of buspirone decreased by approximately 50%. Subjects receiving the higher dosage of buspirone with nefazodone experienced lightheadedness, asthenia, dizziness, and somnolence, although these adverse events also occurred with either drug alone. Buspirone did not have significant effects on the pharmacokinetics of nefazodone. At the 5 mg twice a day dosage, the AUC of nefazodone increased by 23% and that of its metabolites hydroxynefazodone and meta-chlorophenylpiperazine increased by 17% and 9%, respectively. The Cmax of nefazodone and hydroxynefazodone increased by approximately 10% each.

MONITOR CLOSELY: Concomitant use of nefazodone and buspirone may potentiate the risk of serotonin syndrome, which is a rare but serious and potentially fatal condition thought to result from hyperstimulation of brainstem 5-HT1A and 2A receptors. The mechanism involves an additive or synergistic serotonergic effect due to inhibition of serotonin reuptake by nefazodone and activation of serotonin 5-HT1A receptors by buspirone. Serotonin syndrome has been reported with both nefazodone and buspirone in combination with other serotonergic agents.

MANAGEMENT: A lower initial dosage of buspirone (e.g., 2.5 mg/day) is recommended when used in combination with nefazodone. Patients should be closely monitored for the development of serotonin syndrome, which may include mental status changes such as irritability, altered consciousness, confusion, hallucinations, and coma; autonomic dysfunction such as tachycardia, hyperthermia, diaphoresis, shivering, blood pressure lability, and mydriasis; neuromuscular abnormalities such as hyperreflexia, myoclonus, tremor, and ataxia; and gastrointestinal symptoms such as abdominal cramping, nausea, vomiting, and diarrhea. The onset of symptoms is usually rapid--often within a day but sometimes longer--following initiation or addition of a drug, a dosage change, or overdose. If serotonin syndrome develops or is suspected during the course of therapy, both agents should be discontinued immediately and supportive care rendered as necessary. Moderately ill patients may also benefit from the administration of a serotonin antagonist (e.g., cyproheptadine, chlorpromazine, olanzapine, methysergide). Severe cases should be managed under consultation with a toxicologist and may require sedation, neuromuscular paralysis, intubation, and mechanical ventilation in addition to the other measures.

References
  • Margolese HC, Chouinard G "Serotonin syndrome from addition of low-dose trazodone to nefazodone." Am J Psychiatry 157 (2000): 1022
  • Smith DL, Wenegrat BG "A case report of serotonin syndrome associated with combined nefazodone and fluoxetine." J Clin Psychiatry 61 (2000): 146
  • Goldberg RJ, Huk M "Serotonin syndrome from trazodone and buspirone." Psychosomatics 33 (1992): 235-6
  • John L, Perreault MM, Tao T, Blew PG "Serotonin syndrome associated with nefazodone and paroxetine." Ann Emerg Med 29 (1997): 287-9
  • "Product Information. Serzone (nefazodone)." Bristol-Myers Squibb, Princeton, NJ.
  • Corkeron MA "Serotonin syndrome - a potentially fatal complication of antidepressant therapy." Med J Aust 163 (1995): 481-2
  • Sternbach H "The serotonin syndrome." Am J Psychiatry 148 (1991): 705-13
  • Mackay FJ, Dunn NR, Mann RD "Antidepressants and the serotonin syndrome in general practice." Br J Gen Pract 49 (1999): 871-4
  • Metz A "Interaction between fluoxetine and buspirone." Can J Psychiatry 35 (1990): 722-3
  • Nijhawan PK, Katz G, Winter S "Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission." Crit Care Med 24 (1996): 1086-9
  • Manos GH "Possible serotonin syndrome associated with buspirone added to fluoxetine." Ann Pharmacother 34 (2000): 871-4
  • Chan BSH, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG "Serotonin syndrome resulting from drug interactions." Med J Aust 169 (1998): 523-5
  • "Product Information. Buspar (buspirone)." Bristol-Myers Squibb, Princeton, NJ.
Nefazodone Hydrochloride

Generic Name: nefazodone

Brand name: Serzone

Synonyms: Nefazodone

Vanspar

Generic Name: buspirone

Brand name: Buspar, Buspar Dividose, Vanspar, Buspirex, Bustab, LinBuspirone

Synonyms: Vanspar (Oral)

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction